KELLY ROBINSON: Open Payments
NPI 1194385021 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 13 payments from 7 companies in 2025. Trend: 2023 $1,002 · 2024 $449 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $157 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Wegovy, NURTEC ODT, MOUNJARO, CAPLYTA, GEMTESA, TRINTELLIX, JARDIANCE.
Industry payments across IN — which companies pay providers there.
